Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia

被引：0
|
作者：
Zahr, Rima S. [1 ]
Rashkin, Sara R. [2 ]
Ruiz, Maria Armila [3 ]
Elsherif, Laila [4 ]
Ren, Guohui [3 ]
Salas, Guadalupe [3 ]
Ataga, Kenneth I. [4 ]
Gordeuk, Victor R. [3 ]
Lebensburger, Jeffrey [5 ]
Zhang, Xu [3 ]
Saraf, Santosh L. [3 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Div Pediat Nephrol & Hypertens, Memphis, TN 38152 USA
[2] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN USA
[3] Univ Illinois, Div Hematol & Oncol, Chicago, IL 60607 USA
[4] Univ Tennesse, Ctr Sickle Cell Dis, Hlth Sci Ctr, Memphis, TN USA
[5] Univ Alabama Birmingham, Div Pediat Hematol & Oncol, Birmingham, AL USA
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 10期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.3324/haematol.2023.284920
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3368 / 3372
页数：5
相关论文
共 50 条
  • [21] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Anis Ismail
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 1797 - 1810
  • [22] Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
    Ismail, Anis
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (12) : 1797 - 1810
  • [23] Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease
    Velissaris, Dimitrios
    Zareifopoulos, Nicholas
    Koniari, Ioanna
    Karamouzos, Vasilios
    Bousis, Dimitris
    Gerakaris, Andreas
    Platanaki, Christina
    Kounis, Nicholas
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (03): : 133 - 142
  • [24] A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
    Spinale, Joann M.
    Mariani, Laura H.
    Kapoor, Shiv
    Zhang, Jidong
    Weyant, Robert
    Song, Peter X.
    Wong, Hetty N.
    Troost, Jonathan P.
    Gadegbeku, Crystal A.
    Gipson, Debbie S.
    Kretzler, Matthias
    Nihalani, Deepak
    Holzman, Lawrence B.
    KIDNEY INTERNATIONAL, 2015, 87 (03) : 564 - 574
  • [25] Soluble Urokinase Plasminogen Activator Receptor During Allogeneic Stem Cell Transplantation
    Haastrup, E.
    Andersen, J.
    Ostrowski, S. R.
    Hoyer-Hansen, G.
    Jacobsen, N.
    Heilmann, C.
    Ullum, H.
    Muller, K.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2011, 73 (04) : 325 - 329
  • [26] Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease
    Sjowall, Christopher
    Martinsson, Klara
    Cardell, Kristina
    Ekstedt, Mattias
    Kechagias, Stergios
    TRANSLATIONAL RESEARCH, 2015, 165 (06) : 658 - 666
  • [27] Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
    Fueller, D.
    Liu, C.
    Ko, Y. -A.
    Alkhoder, A.
    Desai, S. R.
    Almuwaqqat, Z.
    Patel, S. A.
    Ejaz, K.
    Kauser, T.
    Martini, A.
    Alvi, Z.
    Mehta, P. K.
    Sperling, L. S.
    Quyyumi, A. A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [28] SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Yussef, Sarah Mohammed
    Ursli, Martin
    Rothschild, Inke
    Faraj-Allah, Ayah
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    Hoebaus, Clemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 161 - 161
  • [29] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [30] Soluble Urokinase Plasminogen Activator Receptor Levels Predict Incident Cardio-Kidney-Metabolic Disease Risk
    Yadalam, Adithya
    Liu, Chang
    Sun, Yan
    Quyyumi, Arshed
    CIRCULATION, 2024, 150
12345